Abiopharma

🔍 Hewes L. Becker (Executive)

Company: Galecto, Inc. (GLTO)

Report Date: 2026-01-05

Detailed Transactions and Holdings:

• Acquired 264,629 shares of Common Stock (Direct)
  Date: 2026-01-05 | Code: A | equity_swap_involved: false | shares_owned_after: 264,629.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 528,603 shares of Stock Option (right to buy) at $21.82 per share (Derivative)
  Date: 2026-01-05 | Code: A | Expires: 2036-01-05 | equity_swap_involved: false | shares_owned_after: 528,603.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents the right to receive, at settlement, one share of common stock of the Issuer. The RSUs will vest with respect to 25% on each anniversary of the grant date through the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
• F2: This option represents a right to purchase shares of common stock of the Issuer. This option will vest as to 25% on January 5, 2027 and in equal monthly installments thereafter through January 5, 2030, subject to the Reporting Person's continued service to the Issuer on each such vesting date.